CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 128 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $698,735 | -32.1% | 32,008 | -1.1% | 0.00% | – |
| Q2 2023 | $1,029,169 | +32.2% | 32,374 | +1.4% | 0.00% | – |
| Q1 2023 | $778,431 | -19.5% | 31,916 | +4.1% | 0.00% | – |
| Q4 2022 | $966,795 | +50.4% | 30,653 | +34.6% | 0.00% | – |
| Q3 2022 | $643,000 | +15.2% | 22,778 | +7.8% | 0.00% | – |
| Q2 2022 | $558,000 | -8.5% | 21,124 | +21.4% | 0.00% | – |
| Q1 2022 | $610,000 | +6.1% | 17,400 | -1.9% | 0.00% | – |
| Q4 2021 | $575,000 | -94.5% | 17,744 | -95.0% | 0.00% | -100.0% |
| Q3 2021 | $10,469,000 | +3202.5% | 354,888 | +2772.7% | 0.00% | – |
| Q2 2021 | $317,000 | – | 12,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |